Recurrence of renal cell carcinoma diagnosed using contralateral adrenal biopsy with endoscopic ultrasound-guided fine-needle aspiration

Tanimoto,Azusa; Takeuchi,Shinji; Yaegashi,Hiroshi; Kotani,Hiroshi; Kitai,Hidenori; Nanjo,Shigeki; Ebi,Hiromichi; Yamashita,Kaname; Mouri,Hisatsugu; Ohtsubo,Koushiro; Ikeda,Hiroko; Yano,Seiji

doi:10.3892/mco.2016.739

Recurrence of renal cell carcinoma diagnosed using contralateral adrenal biopsy with endoscopic ultrasound-guided fine-needle aspiration

Authors:
- Azusa Tanimoto
- Shinji Takeuchi
- Hiroshi Yaegashi
- Hiroshi Kotani
- Hidenori Kitai
- Shigeki Nanjo
- Hiromichi Ebi
- Kaname Yamashita
- Hisatsugu Mouri
- Koushiro Ohtsubo
- Hiroko Ikeda
- Seiji Yano
View Affiliations

Affiliations: Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa 920‑0934, Japan, Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa 920‑8641, Japan, Division of Pathology, Kanazawa University Hospital, Kanazawa, Ishikawa 920‑8641, Japan
Published online on: January 25, 2016 https://doi.org/10.3892/mco.2016.739
Pages: 537-540

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

A 76-year-old female in whom a renal cell carcinoma (RCC) lesion was resected 19 years previously presented to our hospital with cognitive dysfunction. Magnetic resonance imaging and computed tomography revealed nodules in the brain, lung, adrenal gland and a pelvic osteolytic lesion. To identify the primary cancer site, the present study performed endoscopic ultrasound‑guided fine‑needle aspiration (EUS‑FNA) of the left adrenal lesion. Consequently, the pathological findings of the tissue obtained by EUS‑FNA were similar to those of the previous nephrectomy specimen, revealing that the adrenal lesion was the recurrence of RCC. The majority of the metastatic lesions in the patient were reduced in size by the multiple kinase inhibitor, pazopanib. Contralateral adrenal metastasis of RCC is rare and the use of EUS‑FNA in the diagnosis of adrenal lesions remains to be elucidated. This is a rare case of adrenal lesion, diagnosed by EUS‑FNA. Therefore, EUS‑FNA is considered to be a useful diagnostic modality of adrenal metastases from unidentified primary tumor types.

View Figures

View References

1	Jonasch E, Gao J and Rathmell WK: Renal cell carcinoma. BMJ. 349:g47972014. View Article : Google Scholar : PubMed/NCBI
2	Saitoh H, Nakayama M, Nakamura K and Satoh T: Distant metastasis of renal adenocarcinoma in nephrectomized cases. J Urol. 127:1092–1095. 1982.PubMed/NCBI
3	Jhala NC, Jhala D, Eloubeidi MA, Chhieng DC, Crowe DR, Roberson J and Eltoum I: Endoscopic ultrasound-guided fine-needle aspiration biopsy of the adrenal glands: Analysis of 24 patients. Cancer. 102:308–314. 2004. View Article : Google Scholar : PubMed/NCBI
4	Chin AI, Lam JS, Figlin RA and Belldegrun AS: Surveillance strategies for renal cell carcinoma patients following nephrectomy. Rev Urol. 8:1–7. 2006.PubMed/NCBI
5	Lipworth L, Tarone RE, Lund L and McLaughlin JK: Epidemiologic characteristics and risk factors for renal cell cancer. Clin Epidemiol. 1:33–43. 2009.PubMed/NCBI
6	Shiao YH, Forsti A, Egevad L, Anderson LM, Lindblad P and Hemminki K: VHL down-regulation and differential localization as mechanisms in tumorigenesis. Kidney Int. 64:1671–1674. 2003. View Article : Google Scholar : PubMed/NCBI
7	Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh FM, et al: Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet. 7:85–90. 1994. View Article : Google Scholar : PubMed/NCBI
8	Mickisch GH, Garin A, van Poppel H, de Prijck L and Sylvester R: European Organisation for Research and Treatment of Cancer (EORTC) Genitourinary Group. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: A randomised trial. Lancet. 358:966–970. 2001. View Article : Google Scholar : PubMed/NCBI
9	Flanigan RC, Salmon SE, Blumenstein BA, Bearman SI, Roy V, McGrath PC, Caton JR Jr, Munshi N and Crawford ED: Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med. 345:1655–1659. 2001. View Article : Google Scholar : PubMed/NCBI
10	Nakano E, Fujioka H, Matsuda M, Osafune M, Takaha M and Sonoda T: Late recurrence of renal cell carcinoma after nephrectomy. Eur Urol. 10:347–349. 1984.PubMed/NCBI
11	Miyao N, Naito S, Ozono S, Shinohara N, Masumori N, Igarashi T, Nakao M, Tsushima T, Senga Y, Horie S, et al: Late recurrence of renal cell carcinoma: Retrospective and collaborative study of the Japanese society of renal cancer. Urology. 77:379–384. 2011. View Article : Google Scholar : PubMed/NCBI
12	Lau WK, Zincke H, Lohse CM, Cheville JC, Weaver AL and Blute ML: Contralateral adrenal metastasis of renal cell carcinoma: Treatment, outcome and a review. BJU Int. 91:775–779. 2003. View Article : Google Scholar : PubMed/NCBI
13	Yoshinaga S, Suzuki H, Oda I and Saito Y: Role of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for diagnosis of solid pancreatic masses. Dig Endosc. 23(Suppl 1): S29–S33. 2011. View Article : Google Scholar
14	Ang TL, Chua TS, Fock KM, Tee AK, Teo EK and Mancer K: EUS-FNA of the left adrenal gland is safe and useful. Ann Acad Med Singapore. 36:954–957. 2007.PubMed/NCBI
15	Motzer RJ, Hutson TE, Cella D, Reeves J, Hawkins R, Guo J, Nathan P, Staehler M, de Souza P, Merchan JR, et al: Pazopanib versus sunitinib in metastatic renal-cell carcinoma. N Engl J Med. 369:722–731. 2013. View Article : Google Scholar : PubMed/NCBI